64
Participants
Start Date
June 21, 2024
Primary Completion Date
October 31, 2027
Study Completion Date
October 31, 2027
LVGN6051 Monoclonal Antibody Injection
LVGN6051 Monoclonal Antibody Injection:1 mg/kg or 2 mg/kg, every 3 weeks(Q3W) , on the first day of the treatment cycle for up to 2 years.
toripalimab Injection
toripalimab Injection: 240mg fixed dose,Q3W, on the first day of the treatment cycle for up to 2 years.
Paclitaxel injection
paclitaxel Injection:5ml:100 mg/m2(80 mg/m2 or 60 mg/m2 can be used if necessary),Q3W,on the first and eighth day of the treatment cycle for up to 2 years
NOT_YET_RECRUITING
Beijing Cancer Hospital, Beijing
NOT_YET_RECRUITING
Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing
NOT_YET_RECRUITING
Liaoning cancer hospital, Shenyang
RECRUITING
Shanghai Oriental Hospital, Shanghai
NOT_YET_RECRUITING
Anhui Cancer Hospital, Hefei
NOT_YET_RECRUITING
Zhejiang Cancer Hospital, Hangzhou
NOT_YET_RECRUITING
Fujian cancer hospital, Fuzhou
NOT_YET_RECRUITING
Xiangya Hospital Central South University, Changsha
NOT_YET_RECRUITING
The Second Xiangya Hospital, Central South University, Changsha
NOT_YET_RECRUITING
Hunan Cancer Hospital, Changsha
NOT_YET_RECRUITING
Hunan Cancer Hospital, Changsha
NOT_YET_RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Henan cancer hospital, Zhengzhou
NOT_YET_RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
Guangxi Medical University Cancer Hospital, Nanning
RECRUITING
West China Hospital of Sichuan University, Chengdu
Lyvgen Biopharma Holdings Limited
INDUSTRY